Gefitinib 250mg Tablet G-Nib

What is the purpose of Gefitinib 250mg Tablet?

In persons with certain types of malignancies, Gefitinib 250mg Tablet is used to treat non-small cell lung cancer that has progressed to other regions of the body. Gefitinib belongs to the kinase inhibitor class of drugs.

When should I take 250 mg of gefitinib?

Gefitinib should be taken once a day, with or without meals, as advised by your doctor. Place the pill in a glass of water (4 to 8 ounces/120 to 240 milliliters) if you have problems swallowing it. 15 minutes of vigorous stirring Immediately consume the entire combination.

Is gefitinib capable of curing lung cancer?

Tyrosine kinase inhibitors (TKIs) like gefitinib are extremely effective for non-small cell lung cancer (NSCLC) by activating EGFR mutations, however, no cured case of advanced NSCLC has been documented yet. The first case of EGFR-mutated lung cancer treated with gefitinib is presented here.

What are the Gefitinib 250mg Tablet side effects?

• Consequences
• Tenderness or pain in the abdomen or stomach.
• Stools are made of clay.
• appetite reduction
• severe diarrhea
• Skin rash or itching
• vomiting and nausea
• Inflammation of the foot or lower legs.
• Yellow skin or eyes

For more details Click Here.

How long may Gefitinib 250mg Tablet be taken?

Chemotherapy is a fairly normal program of infusions every three weeks for four cycles — of 12 weeks of treatment — while gefitinib is a daily medication that they take for two years.

Is gefitinib an anti-cancer drug?

Patients with advanced non–small-cell lung cancer who get cytotoxic chemotherapy have a response rate of 20 to 35 percent and a median survival period of 10 to 12 months. Gefitinib is a tyrosine kinase inhibitor of the epidermal growth factor receptor that is taken orally (EGFR).

Does gefitinib make you scratch?

In patients on EGFR inhibitors, dry skin is very prevalent; vaginal dryness and itching, perineal dryness, and blepharitis have all been described.

Is Gefitinib 250mg Tablet considered a TKI?

Gefitinib was the first epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to be approved for advanced non-small cell lung cancer treatment (NSCLC).

We are a global wholesaler and exporter from India and operate in more than 5 countries like UAE, USA, Italy, Germany, Brazil, etc. If you are looking for another product or brand click on our products.